Before prescription drugs and biomedical devices get to market, they undergo years of pharmaceutical development through research and testing in accordance with FDA standards. From microencapsulation to assessment of bioengineered materials and biomedical devices, our experienced scientists and engineers assist in drug and biologic discovery in our world-class, FDA-inspected CGMP facilities and under inspected ISO 13485 protocols. We support drug development from preclinical to clinical trials. Those services include computational drug design, synthetics, formulation and CGMP clinical supplies, chemical process and analytical development, and project management.
Production & Manufacturing Solutions
SwRI offers small-molecule, medical device and biologic development services under our current FDA license.
Learn MoreIntroduction to Pharmaceutical Development
SwRI is hosting an in-person, 2-day workshop Feb. 24-25, 2025, introducing participants to a variety of pharma topics starting with the active pharmaceutical ingredient (API) and finishing with regulatory approval.
Access WorkshopWith extensive experience in microencapsulation and formulation, we can quickly develop solutions for formulation and drug delivery problems such as solubility, stability, controlled delivery, delayed release, taste and targeting. Our experienced team can develop processes to overcome process hurdles including safety, scalability and specialized purifications.
